CompletedNCT05046184
Brain imaging of irritability and ketamine in depression
About this title
Read the official source — NCT05046184Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- DallasSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: May 5, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 104
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05046184
- Official title
Show the full official title
Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Dallas
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Texas Southwestern Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including Ketamine Hydrochloride and Midazolam injection.
Who was this study for?
Listed age limits: 18 years to 65 years.
